天才体育数据
GENI
6.35
-0.23
-3.50%
天才体育数据
US · GENI
#2921 按市值排名
上市于 1970
6.35
-0.23
-3.50%
实时 - 追踪5344个代码 - 心跳于512秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 机构持股总比例下降了1.3个百分点。
机构持股
- 机构持股比例
- 91.82% -1.28pp
- 机构数量
- 326
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund56.08%
Hedge Fund27.72%
Individual/Insider8.45%
Public Company3.30%
Family Office/Trust1.87%
Sovereign Wealth Fund1.28%
Private Company0.95%
Insurance Company0.56%
主要股东 截至 2026-06-30
BlackRock
7.39% · 19.77M 股
Mark Locke
7.24% · 19.38M 股
Senvest Management, LLC
5.93% · 15.88M 股
Glenview Capital Management, LLC
5.04% · 13.50M 股
Hood River Capital Management LLC
4.83% · 12.93M 股
Stephens Investment Management Group, LLC
4.00% · 10.69M 股
Shapiro Capital Management LLC
3.69% · 9.89M 股
Frontier Capital Management
3.52% · 9.43M 股
Discovery Capital Management, LLC
2.70% · 7.23M 股
Portolan Capital Management, LLC
2.63% · 7.03M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 5次买入 · 27次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Mark Locke | Chief Executive Officer | 7.24% |
| Jack Davison | Chief Commercial Officer | 0.76% |
| Thomas Russell | Chief Legal Officer | 0.18% |
| Nicholas Taylor | Chief Financial Officer | 0.09% |
| Daniel Burns | Director | 0.06% |
| Kenneth Kay | Independent Director | 0.05% |
| Kimberly Williams-Bradley | Independent Director | 0.03% |
| Robert Bach | Independent Director | 0.02% |
| Claire Valoti | Independent Director | 0.01% |
| Bertrand Castellani | -- | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-10-01 | Bertrand Castellani | -- | Derivative Exercise and Sale | -53,297 | $5.68 |
| 2026-10-01 | Bertrand Castellani | -- | Derivative Exercise and Retained | +98,474 | -- |
| 2026-09-16 | Mark Locke | Chief Executive Officer | Open Market Disposition | -800,000 | $6.54–6.58 |
| 2026-09-16 | Thomas Russell | Chief Legal Officer | Open Market Disposition | -50,000 | $6.51 |
| 2026-09-14 | Mark Locke | Chief Executive Officer | Open Market Derivative Acquisiti | +1 | $5.00 |
| 2026-09-14 | Mark Locke | Chief Executive Officer | Open Market Derivative Dispositi | -1 | $10.20 |
| 2026-03-19 | Mark Locke | Chief Executive Officer | Derivative Exercise and Sale | -7,800 | $4.53 |
| 2026-03-19 | Mark Locke | Chief Executive Officer | Derivative Exercise and Retained | +112,200 | -- |
| 2026-03-19 | Jack Davison | Chief Commercial Officer | Derivative Exercise and Sale | -35,250 | $4.53 |
| 2026-03-19 | Jack Davison | Chief Commercial Officer | Derivative Exercise and Retained | +39,750 | -- |
| 2026-03-19 | Thomas Russell | Chief Legal Officer | Derivative Exercise and Sale | -16,450 | $4.53 |
| 2026-03-19 | Thomas Russell | Chief Legal Officer | Derivative Exercise and Retained | +18,550 | -- |
| 2026-03-17 | Kenneth Kay | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Robert Bach | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Mark Locke | Chief Executive Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Claire Valoti | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Bertrand Castellani | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Daniel Burns | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Jack Davison | Chief Commercial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Thomas Russell | Chief Legal Officer | Initial Statement of Beneficial | 0 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
天才体育数据 讨论区 0 条评论